<DOC>
	<DOCNO>NCT02933905</DOCNO>
	<brief_summary>Influence vitreomacular interface progression diabetic macular edema treatment intravitreal injection vascular endothelial growth factor inhibitor</brief_summary>
	<brief_title>Influence Vitreomacular Interface Progression Diabetic Macular Edema After Anti-VEGF Injection</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>diabetic macular edema treatable antiangiogenic drug age 18 cardiovascular event last year previous vitrectomy previous macular edema treatment last 4 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>